Our Lalmin® Cr is an inactivated dried whole cell yeast (Saccharomyces cerevisiae) containing elevated levels ofchromium. The natural yeast fermentation is supplemented with low levels of chromium, the yeast cream is pasteurized and then spray dried or roller-dried/grinded. This process allows the mineral to interact with the yeast cell components and the gentle processing conditions then preserve the level of the essential minerals, vitamins and other micro-nutrients.
Our Lalmin® Cr is grown from special strains of yeast on natural ingredients enriched with chromium. Primary grown high chromium yeast is reported to have significantly greater level of biologically active chromium than inorganic chromium.
IMPORTANCE OF CHROMIUM IN HUMAN DIET
Chromium enriched yeast helps to normalize blood sugar potentiating the action of insulin (Glucose Tolerance Factor) and plays an important role in the metabolism of fats and carbohydrates.
- Chromium is an essential nutrient required for normal carbohydrate and fat metabolism. Insufficient dietary intake of chromium leads to signs and symptoms that are similar to those observed in diabetes and cardiovascular diseases.
- Supplemental chromium given to people with impaired glucose tolerance or diabetes leads to improved blood glucose, insulin, and lipid variables.
- Strenuous exercise, high sugar diets and physical trauma result in high chromium losses and increase the need for chromium supplements. Chromium has been also shown to improve lean body mass in humans and certain animals.
- A significantly increased rate of growth was observed in a group of malnourished children given a chromium supplement.
- Response to chromium is dependent upon the form and the amount of supplemental chromium. Chromium yeast is an excellent source of biologically active chromium.
- Chromium potentiates or enhances the action of insulin, it does not replace insulin. With an optimum level of chromium in the body, less insulin is required to keep glucose levels under control.
- A study with diabetics showed that inorganic chromium was ineffective in improving glucose tolerance while a six-month supplement of high chromium yeast normalized the glucose tolerance as measured by the glucose tolerance test
High chromium yeast is a biologically active form of chromium and is better absorbed than inorganic chromium. High chromium yeast is the preferred form of chromium for nutrition supplements
- Dietary intake of chromium in the U.S and most industrialized countries is suboptimal due to the extensive processing of our foods. The estimated and safe daily intake for chromium is 50 to 200 micrograms. Most diets, however, contain less than 60% of the minimum suggested intake.
- Glucose Tolerance Factor (GTF) has been shown to be related to normal carbohydrate metabolism.
- Biologically active chromium supplements, such as high chromium yeast, will decrease blood sugar of people with elevated glucose values (hyperglycemic) and increase that of those with low blood sugar (hypoglycemic).
CHROMIUM – AN ESSENTIAL TRACE ELEMENT IN LIPID METABOLISM
Improvements in overall lipid metabolism, like those for glucose and insulin variables, are dependent upon the amount of supplemental chromium. Suboptimal chromium intake is associated with signs and symptoms of chromium deficiency that are similar to those for cardiovascular diseases.
- Total cholesterol, low density lipoprotein (LDL)- and high density lipoprotein (HDL) -cholesterol, total cholesterol / HDL ratio, and triglycerides have all been shown to improve in humans as well as experimental animals following chromium supplementation.
- Chromium supplementation of elderly subjects causes significant decreases in total cholesterol with larger decreases in subjects with the highest levels prior to supplementation.
- Chromium supplementation in test group of men led to significant decreases in serum triglycerides and increases in HDL-cholesterol compared to placebo-treated subjects.
- Chromium supplementation of patients being treated for diabetes led to significant improvements in diabetic symptoms and also increases in HDL-cholesterol.
- Daily supplementation of chromium substantially increases HDL-cholesterol, considered one of the best indicators of risk of heart diseases.
- Toxic effects of supplemental chromium are improbable. No documented signs of chromium toxicity have been reported in the many chromium supplementation studies over the past three decades.
GLUCOSE TOLERANCE FACTOR
Chromium is recognized as a trace element essential for human nutrition and it must be obtained from the diet. Chromium, as the central part of Glucose Tolerance Factor (GTF), enhances the effect of insulin in the body. This factor improves glucose tolerance and insulin efficacy. LalminÔ – Cr contains high levels of organic chromium that is available for GTF.
1. Anderson RA, Polansky MM, Bryden NA, Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr, 1991; 54:909-16
2. Anderson RA and Kozlowsky AS. Chromium intake, absorption and excretion of subjects consuming self-selected diets. American J of Clinical Nutrition, 1985;41:1177
3. Anderson, R. A. Chromium as an essential nutrient for humans. Regulatory Toxicology and pharmacology 1997, 26, S35-S41.
4. Anderson RA. Chromium, glucose tolerance, diabetes and lipid metabolism. J of Advancement in Medicine, Spring, 1995;8(1):36
5. Anderson RA. Chromium and parenteral nutrition. Nutrition, 1995; 11:83
6. Lukaski HC, Bolonchuck WW, Siders WA, et. al. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. American J of Clin Nutrition, 1996;63:954
7. Lee NA and Reasner CA. Beneficial effects of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care, Dec. 1994;17(12):1449
8. Morris BW, MacNeil S, Stanley K, et. al. The inter-relationship between insulin and chromium in hyperinsulinemic euglycemic clamps in healthy volunteers. J of Endocrinology, 1993;139:339
9. Roeback JR Jr, Hla KM, Chambless LE, et. al. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. Annals of Internal Medicine, December 15, 1991;115:917
10. Wilson BE and Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Research and Clinical Practice, 1995;28:179